Back to search

France· FR:68147829

CLINDAMYCINE KALCEKS 600 mg/4 mL, solution injectable/pour perfusion

A medicinal product containing phosphate de clindamycine, registered in France by AS KALCEKS (LETTONIE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCLINDAMYCINE KALCEKS 600 mg/4 mL, sol…ATC—REGISTER NO.FR:68147829PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PHOSPHATE DE CLINDAMYCINE
Manufacturer
AS KALCEKS (LETTONIE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955103028
    10 ampoules en verre de 4 mL

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Phosphate de clindamycine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phosphate de clindamycine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Clindac, Clindamycin 1a Pharma
  • Belgium · Clindamycin Noridem, Clindamycin Sandoz
  • Bulgaria · Clindamycin Kabi, Далацин C
  • Cyprus · Arfarel, Clindamycin Abr
  • Czechia · Clindamycin Hameln, Clindamycin Kabi
  • Germany · Clinda-Ipp, Clinda-Saar
  • Denmark · Clindamycin Abcur, Clindamycin Alternova
  • Estonia · Clindamycin Mip, Dalacin
  • Spain · Clindamicina Aristo, Clindamicina Kalceks
  • Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
  • United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
  • Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
  • Croatia · Aknet, Dalacin
  • Hungary · Clindamycin Anfarm, Clindamycin Hameln
  • Ireland · Clindamycin, Clindamycin Kalceks
  • Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
  • Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
  • Lithuania · Clindamycin Mip, Dalacin C
  • Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
  • Latvia · Clindamycin Kalceks, Clindamycin Mip
  • Malta · Clidacin Ba Free Amp, Clindamicina Accord
  • Netherlands · Clindamycin Teva, Clindamycine Added Pharma
  • Norway · Clindamycin Abcur, Clindamycin Kalceks
  • Poland · Clindacne, Clindalin
  • Portugal · Clincina, Clindamicina Generis
  • Romania · Clindamicină Hameln, Clindamycin Mip
  • Sweden · Clindamycin Abcur, Clindamycin Actavis
  • Slovenia · Dalacin, Klimicin
  • Slovakia · Clindamycin Hameln, Clindamycin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd2d64c2-67ce-4e6b-815d-df4ee40c735e
GET /v1/drugs/fd2d64c2-67ce-4e6b-815d-df4ee40c735e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68147829",
  "date_amm": "2024-08-13",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "PHOSPHATE DE CLINDAMYCINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable ou pour perfusion",
  "voies_administration": "intramusculaire;intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about phosphate de clindamycine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.